Home > Press > Chad A. Mirkin to Deliver Pittcon 2011 Plenary Lecture
Abstract:
Most Cited Chemist in the World (Thomson Reuters)
The Pittcon Program Committee is pleased to announce that Dr. Chad A. Mirkin, Professor of Chemistry, Northwestern University, Evanston, Illinois, will deliver the Pittcon 2011 Plenary Lecture, "Polyvalent DNA Architectures: New Modalities For Intracellular Gene Regulation and Detection" on Sunday, March 13, 2011, at 4:30 p.m., in the Sidney Marcus Auditorium, Georgia World Congress Center, Atlanta, Georgia.
Dr. Chad A. Mirkin is the Director of the International Institute for Nanotechnology, the George B. Rathmann Professor of Chemistry, Professor of Chemical and Biological Engineering, Professor of Biomedical Engineering, Professor of Materials Science & Engineering, and Professor of Medicine."
Dr. Mirkin summarizes, "Over the past decade, we have developed methods for modifying nanoparticles with oligonucleotides and explored how they can be used as designer constructs for preparing highly ordered, highly functional materials. Over the course of these studies, we have discovered many unusual fundamental properties that make these materials particularly useful in biodiagnostics and intracellular gene regulation."
This lecture will focus on the use of these modified nanoparticles in the highly selective and sensitive detection of nucleic acids and proteins. It will also introduce the concept of the "antisense" particle and other similarly functionalized particles. Such particles exhibit a range of unique properties that make them very well-suited for gene regulation. They can also be tailored to control the binding strength to complementary target sequences offering a means to control the degree of protein expression.
See complete abstract here: www.pittcon.org/technical/pdfs/2011/Mirkin_Abstract.pdf
Mirkin is a chemist and a world renowned nanoscience expert, who is known for his development of nanoparticle-based biodetection schemes, the invention of Dip-Pen Nanolithography, and contributions to supramolecular chemistry. He is the author of over 410 manuscripts and over 370 patents and applications, and the founder of three companies, Nanosphere, NanoInk, and AuraSense which are commercializing nanotechnology applications in the life science and semiconductor industries. At present, he is listed as the most cited chemist in the world (Thomson Reuters), and the top most cited nanomedicine researcher in the world (Nanomedicine Registry).
Dr. Mirkin has been recognized for his accomplishments with over 60 national and international awards.
The Plenary Lecture will be part of the Opening Session for Pittcon 2011 which will be held in Atlanta, Georgia, from March 13-18, 2011, Georgia World Congress Center. The Plenary Lecture is followed immediately by a complimentary mixer and poster session. Visit www.pittcon.org/ to get more information on Pittcon 2011.
####
For more information, please click here
Contacts:
Contact:
Melinda Stephens
Marian Nardozzi
800-825-3221
Copyright © Pittcon 2011
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||